The potential for targeting the STAT3 pathway as a novel therapy for melanoma

Future Oncol. 2013 Jul;9(7):925-7. doi: 10.2217/fon.13.83.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Drug Design
  • Drug Resistance, Neoplasm
  • Humans
  • Indoles / pharmacology
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / metabolism
  • Mice
  • Molecular Targeted Therapy / methods*
  • RNA, Small Interfering
  • STAT3 Transcription Factor / antagonists & inhibitors
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism*
  • Sulfonamides / pharmacology
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • RNA, Small Interfering
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Sulfonamides
  • Vemurafenib